世界の低分子量ヘパリン市場レポート2020年

QYResearchが発行した調査報告書(QYR21FB8275)
◆英語タイトル:Global Low Molecular Weight Heparin Sales Market Report 2020
◆商品コード:QYR21FB8275
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:137
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:材料、化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の低分子量ヘパリン市場について種類別(エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン)、用途別(静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・低分子量ヘパリン市場の概要
・世界の主要地域別低分子量ヘパリン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の低分子量ヘパリン市場規模2015-2026:種類別(エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン)
・世界の低分子量ヘパリン市場規模2015-2026:用途別(静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他)
・低分子量ヘパリンのアメリカ市場規模2015-2020
・低分子量ヘパリンのヨーロッパ市場規模2015-2020
・低分子量ヘパリンの中国市場規模2015-2020
・低分子量ヘパリンの日本市場規模2015-2020
・低分子量ヘパリンの東南アジア市場規模2015-2020
・低分子量ヘパリンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・低分子量ヘパリンの製造コスト分析
・販売チャネル、流通業者、顧客
・低分子量ヘパリンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second’s largest market with the share of 30.49%.
At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.
China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.
In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.
Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.

Market Analysis and Insights: Global Low Molecular Weight Heparin Market
The global Low Molecular Weight Heparin market size is projected to reach US$ 440.4 million by 2026, from US$ 321.2 million in 2020, at a CAGR of 5.4% during 2021-2026.

Global Low Molecular Weight Heparin Scope and Market Size
The global Low Molecular Weight Heparin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Low Molecular Weight Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Low Molecular Weight Heparin market is segmented into
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Segment by Application, the Low Molecular Weight Heparin market is segmented into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

The Low Molecular Weight Heparin market is analysed and market size information is provided by regions (countries). Segment by Application, the Low Molecular Weight Heparin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Low Molecular Weight Heparin Market Share Analysis
Low Molecular Weight Heparin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Low Molecular Weight Heparin business, the date to enter into the Low Molecular Weight Heparin market, Low Molecular Weight Heparin product introduction, recent developments, etc.

The major vendors covered:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

【レポートの目次】

1 Low Molecular Weight Heparin Market Overview
1.1 Low Molecular Weight Heparin Product Scope
1.2 Low Molecular Weight Heparin Segment by Type
1.2.1 Global Low Molecular Weight Heparin Sales by Type (2020-2026)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Low Molecular Weight Heparin Segment by Application
1.3.1 Global Low Molecular Weight Heparin Sales Comparison by Application (2020-2026)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Low Molecular Weight Heparin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Low Molecular Weight Heparin Sales Growth Rate (2015-2026)
1.4.2 Global Low Molecular Weight Heparin Revenue and Growth Rate (2015-2026)
1.4.3 Global Low Molecular Weight Heparin Price Trends (2015-2026)

2 Low Molecular Weight Heparin Estimate and Forecast by Region
2.1 Global Low Molecular Weight Heparin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Low Molecular Weight Heparin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Low Molecular Weight Heparin Sales Market Share by Region (2015-2020)
2.2.2 Global Low Molecular Weight Heparin Revenue Market Share by Region (2015-2020)
2.3 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Low Molecular Weight Heparin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Low Molecular Weight Heparin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.2 Europe Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.3 China Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.4 Japan Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.6 India Low Molecular Weight Heparin Estimates and Projections (2015-2026)
3 Global Low Molecular Weight Heparin Competition Landscape by Players
3.1 Global Top Low Molecular Weight Heparin Players by Sales (2015-2020)
3.2 Global Top Low Molecular Weight Heparin Players by Revenue (2015-2020)
3.3 Global Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Low Molecular Weight Heparin as of 2019)
3.4 Global Low Molecular Weight Heparin Average Price by Company (2015-2020)
3.5 Manufacturers Low Molecular Weight Heparin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Low Molecular Weight Heparin Players (Opinion Leaders)
4 Global Low Molecular Weight Heparin Market Size by Type
4.1 Global Low Molecular Weight Heparin Historic Market Review by Type (2015-2020)
4.1.1 Global Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
4.1.2 Global Low Molecular Weight Heparin Revenue Market Share by Type (2015-2020)
4.1.3 Global Low Molecular Weight Heparin Price by Type (2015-2020)
4.2 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Low Molecular Weight Heparin Sales Forecast by Type (2021-2026)
4.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Type (2021-2026)
4.2.3 Global Low Molecular Weight Heparin Price Forecast by Type (2021-2026)
5 Global Low Molecular Weight Heparin Market Size by Application
5.1 Global Low Molecular Weight Heparin Historic Market Review by Application (2015-2020)
5.1.1 Global Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
5.1.2 Global Low Molecular Weight Heparin Revenue Market Share by Application (2015-2020)
5.1.3 Global Low Molecular Weight Heparin Price by Application (2015-2020)
5.2 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Low Molecular Weight Heparin Sales Forecast by Application (2021-2026)
5.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Application (2021-2026)
5.2.3 Global Low Molecular Weight Heparin Price Forecast by Application (2021-2026)

6 United States Low Molecular Weight Heparin Market Facts & Figures
6.1 United States Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
6.2 United States Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
6.3 United States Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)

7 Europe Low Molecular Weight Heparin Market Facts & Figures
7.1 Europe Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
7.2 Europe Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
7.3 Europe Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)

8 China Low Molecular Weight Heparin Market Facts & Figures
8.1 China Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
8.2 China Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
8.3 China Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)

9 Japan Low Molecular Weight Heparin Market Facts & Figures
9.1 Japan Low Molecular Weight Heparin Sales Market Share by Company (3015-3030)
9.2 Japan Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
9.3 Japan Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)

10 Southeast Asia Low Molecular Weight Heparin Market Facts & Figures
10.1 Southeast Asia Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)

11 India Low Molecular Weight Heparin Market Facts & Figures
11.1 India Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
11.2 India Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
11.3 India Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Low Molecular Weight Heparin Business
12.1 Aspen
12.1.1 Aspen Corporation Information
12.1.2 Aspen Business Overview
12.1.3 Aspen Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Aspen Low Molecular Weight Heparin Products Offered
12.1.5 Aspen Recent Development
12.2 Sanofi-aventis
12.2.1 Sanofi-aventis Corporation Information
12.2.2 Sanofi-aventis Business Overview
12.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi-aventis Low Molecular Weight Heparin Products Offered
12.2.5 Sanofi-aventis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Low Molecular Weight Heparin Products Offered
12.3.5 Pfizer Recent Development
12.4 Opocrin
12.4.1 Opocrin Corporation Information
12.4.2 Opocrin Business Overview
12.4.3 Opocrin Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Opocrin Low Molecular Weight Heparin Products Offered
12.4.5 Opocrin Recent Development
12.5 CSBIO
12.5.1 CSBIO Corporation Information
12.5.2 CSBIO Business Overview
12.5.3 CSBIO Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CSBIO Low Molecular Weight Heparin Products Offered
12.5.5 CSBIO Recent Development
12.6 Dongying Tiandong Pharmaceutical
12.6.1 Dongying Tiandong Pharmaceutical Corporation Information
12.6.2 Dongying Tiandong Pharmaceutical Business Overview
12.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Products Offered
12.6.5 Dongying Tiandong Pharmaceutical Recent Development
12.7 Changzhou Qianhong Bio-pharma
12.7.1 Changzhou Qianhong Bio-pharma Corporation Information
12.7.2 Changzhou Qianhong Bio-pharma Business Overview
12.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Products Offered
12.7.5 Changzhou Qianhong Bio-pharma Recent Development
12.8 Techdow
12.8.1 Techdow Corporation Information
12.8.2 Techdow Business Overview
12.8.3 Techdow Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Techdow Low Molecular Weight Heparin Products Offered
12.8.5 Techdow Recent Development
12.9 Yantai Dongcheng Pharmaceutical Group
12.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
12.9.2 Yantai Dongcheng Pharmaceutical Group Business Overview
12.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Products Offered
12.9.5 Yantai Dongcheng Pharmaceutical Group Recent Development

13 Low Molecular Weight Heparin Manufacturing Cost Analysis
13.1 Low Molecular Weight Heparin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Low Molecular Weight Heparin
13.4 Low Molecular Weight Heparin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Low Molecular Weight Heparin Distributors List
14.3 Low Molecular Weight Heparin Customers

15 Market Dynamics
15.1 Low Molecular Weight Heparin Market Trends
15.2 Low Molecular Weight Heparin Opportunities and Drivers
15.3 Low Molecular Weight Heparin Market Challenges
15.4 Low Molecular Weight Heparin Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【掲載企業】

Aspen、Sanofi-aventis、Pfizer、Opocrin、CSBIO、Dongying Tiandong Pharmaceutical、Changzhou Qianhong Bio-pharma、Techdow、Yantai Dongcheng Pharmaceutical Group

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の低分子量ヘパリン市場レポート2020年(Global Low Molecular Weight Heparin Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。